Healthcare Analytics, Population Health Management, Healthcare Big Data

Population Health News

Google’s Verily to Open Data-Driven Opioid Treatment Center

Verily and local health system partners in Ohio will open a data-driven physical campus dedicated to opioid abuse treatment and recovery.

Opioid treatment and recovery

Source: OneFifteen

By Jennifer Bresnick

- Verily, the health data innovation company owned by Google parent company Alphabet, is developing a physical campus dedicated to opioid treatment with a data-driven twist.

The OneFifteen project, a “not-for-profit healthcare ecosystem” dedicated to opioid addition treatment and recovery, will be located in Dayton, Ohio. 

Regional healthcare providers, including Kettering Health Health Network and Premier Health, will collaborate with Verily to offer treatment, tools, and resources to individuals with substance abuse needs.

“Addiction is a disease best defeated through a public health mindset,” said Mike Maiberger, executive vice president and chief operating officer at Premier Health.

“The Dayton community has put a dent in our overdose crisis by adopting this mindset and through collaboration. OneFifteen's evidence-based approach should, over time, fine-tune local efforts to prevent and treat substance abuse and heal our communities.”

READ MORE: Nearly 50% of Nurses See Opioids as a Top Population Health Concern

The health center, which will open in the Spring of 2019, will serve as a learning laboratory for analysts looking into how to prevent the continued spread of one of the nation’s deadliest public health crises.

“Americans under 50 years old are more likely to die from an unintended overdose than any other cause, and two-thirds of those deaths involve an opioid. In 2017, 115 people died each day from opioid overdoses in the United States and that number continues to rise,” wrote Danielle Schlosser, Senior Clinical Scientist, Behavioral Health at Verily.

“We are in the midst of a public health emergency. At Verily, we are focused on making health information useful so people can live healthier lives, and in the face of one of the greatest public health crises the US has seen, we feel compelled to act.”

Verily researchers, clinicians, and engineers analyzed data about the opioid crisis to better understand how substance abuse takes hold in communities and what challenges these communities are facing when addressing the widespread problem.

“We recognized that a common thread through these challenges was the absence of high-quality information to guide individuals, communities, and legislators to adopt treatment models that they are confident will support prevention and recovery.”

READ MORE: Geisinger Population Health Program Cuts Opioid Use by 18%

“Leaning into our capabilities of building health platforms, we are setting out to create a ‘learning health system’ that aims to address this critical information gap in addiction medicine,” Schlosser said.

The OneFifteen campus will generate data that can be used to develop new approaches to care and best practices for the treatment of opioid abuse.

“We are thrilled to launch OneFifteen in Dayton, Ohio, to support the recovery of people suffering from opioid use disorder, and over time other substance use disorders,” said Marti Taylor, president and chief executive officer of OneFifteen.

“Recovery is not a 28-day process and requires a long-term, holistic approach for success. OneFifteen will offer evidence-based care that addresses the many unmet needs of people in recovery, including vocational training and sober living. By taking a community-based, partnership-driven approach, the OneFifteen ecosystem is working to establish a virtuous cycle of recovery, creating an environment conducive to broader rehabilitation efforts.”

The campus will also offer insights into how physical environments affect recovery and the likelihood of relapse, Verily said.

READ MORE: Analytics Help Christiana Care Cut ED Opioid Prescriptions by Half

“As many healthcare providers can attest, sustained recovery is as much about the environment that a person is in and returns to, as it is about an individual’s medical treatment and personal goals,” wrote Schlosser.

“People living with addiction need multidimensional and easy-to-access treatment. We recognize that if the full continuum of care as well as other services like recovery housing and vocational training could be in one location, it could produce better outcomes for patients and their loved ones.”

With the help of Alexandria Real Estate Equities, Verily and its partner health systems are working to collocate clinical services, recovery housing, and mixed-use facilities to create a community of support with easy access to key services.

“Dayton has been at the epicenter of our national addiction crisis, and we have worked to share what we've learned through that experience with other communities,” said Dayton Mayor Nan Whaley.

“OneFifteen's focus on continuously learning how to improve addiction treatment aligns closely with our community's innovative and collaborative approach to this issue. I am thrilled to welcome OneFifteen to Dayton to join our robust ecosystem of partners tackling opioid addiction.”

Verily is also partnering with community organizations to revitalize the surrounding neighborhood and extend investments into the region.

“OneFifteen, and its team of community partners, will strive to provide treatments that offer sustained recovery and a path forward to the many who are fighting to manage their addiction,” Schlosser said.

“This is not a short-term undertaking and it will require deep commitment from all of the partners and the broader community to have an impact on this complex issue.”

“We hope that the work of OneFifteen will be a cornerstone in advancing the field of addiction medicine, demonstrating the value of investing in behavioral health and improving the health of communities. We look forward to working with the OneFifteen team on this ambitious endeavor.”


Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks

Continue to site...